Otsuka Holdings
4578.T
#596
Rank
NZ$73.83 B
Marketcap
NZ$141.00
Share price
0.62%
Change (1 day)
48.88%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

P/S ratio for Otsuka Holdings (4578.T)

P/S ratio as of November 2026 (TTM): 2.40

According to Otsuka Holdings 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.95. At the end of 2026 the company had a P/S ratio of 2.22.

P/S ratio history for Otsuka Holdings from 2010 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20262.2222.69%
20251.81-6.72%
20241.9435.16%
20231.437.19%
20221.34-8.99%
20211.47-15.01%
20201.73-8.87%
20191.900.77%
20181.88-12.36%
20172.15-0.74%
20162.1733.59%
20151.6227.82%
20141.2712.45%
20131.132.17%
20121.101.52%
20111.0918.85%
20100.9150